We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

156 hedge funds and large institutions have $2.39B invested in Agios Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital invested

Capital invested by funds: $1.63B → $2.39B (+$764M)

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

4.16% more ownership

Funds ownership: 92.87% → 97.02% (+4.2%)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

3% less funds holding

Funds holding: 161 → 156 (-5)

20% less call options, than puts

Call options by funds: $14.3M | Put options by funds: $17.9M

Holders
156
Holders Change
-5
Holders Change %
-3.11%
% of All Funds
3.88%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
26
Increased
59
Reduced
45
Closed
25
Calls
$14.3M
Puts
$17.9M
Net Calls
-$3.57M
Net Calls Change
-$29.5M

Top Buyers

1
BlackRock
BlackRock
New York
+$103M
2
Goldman Sachs
Goldman Sachs
New York
+$27.4M
3
Norges Bank
Norges Bank
Norway
+$20.6M
4
Invesco
Invesco
Georgia
+$10.9M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$8.82M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$9.82M
2
CCI
Columbus Circle Investors
-$9.1M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$5.35M
4
UBS Group
UBS Group
Switzerland
-$2.65M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Casdin Capital
New York
$13.9M -$144K -3,000 -1%
Northern Trust
27
Northern Trust
Illinois
$10.3M +$899K +18,745 +12%
CS
28
Credit Suisse
Switzerland
$10.1M +$2.13M +44,332 +35%
Jennison Associates
29
Jennison Associates
New York
$9.92M – – –
Deutsche Bank
30
Deutsche Bank
Germany
$9.7M +$1M +20,876 +14%
BNP Paribas Asset Management
31
BNP Paribas Asset Management
France
$9.34M +$1.34M +28,025 +21%
CIS
32
Capital International Sarl
California
$8.94M -$451K -9,400 -6%
Lord, Abbett & Co
33
Lord, Abbett & Co
New Jersey
$8.59M -$708K -14,762 -9%
OM
34
Opaleye Management
Massachusetts
$7.59M – – –
BBA
35
Baker Bros. Advisors
New York
$7.51M – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$7.4M -$61.9K -1,291 -1%
ACH
37
ArrowMark Colorado Holdings
Colorado
$7.36M +$3M +62,555 +99%
GTC
38
Ghost Tree Capital
New York
$7.3M -$719K -15,000 -11%
HRCM
39
Hood River Capital Management
Florida
$6.79M +$188K +3,929 +3%
CGL
40
Clarius Group LLC
Washington
$6.38M – – –
TCIM
41
TIAA CREF Investment Management
New York
$5.21M -$214K -4,462 -5%
Capital Fund Management (CFM)
42
Capital Fund Management (CFM)
France
$5.15M +$4.23M +88,185 New
CII
43
Capital International Inc
California
$5.01M -$14.4K -300 -0.3%
Charles Schwab
44
Charles Schwab
California
$4.87M +$343K +7,158 +9%
Barclays
45
Barclays
United Kingdom
$4.63M +$1.29M +26,943 +51%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$4.27M +$214K +4,471 +7%
QIM
47
Quantitative Investment Management
Virginia
$4.15M +$3.41M +71,100 New
Morgan Stanley
48
Morgan Stanley
New York
$3.76M -$937K -19,537 -23%
Axa
49
Axa
France
$3.75M -$93.3K -1,947 -3%
Point72 Asset Management
50
Point72 Asset Management
Connecticut
$3.65M -$1.8M -37,500 -38%
1
2
3 4 5

AGIO Hedge Fund Activity: Q1 2017 in Review

156 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q1 2017, worth a combined $2.39B — up 47% from $1.63B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new AGIO positions and 25 closed out — a net gain of 1 holder — while 59 added to existing stakes and 45 trimmed.

The largest buyer was BlackRock, adding an estimated $103M. The largest seller was Millennium Management, cutting an estimated $9.82M.

  • 156 institutional investors held Agios Pharmaceuticals (AGIO) as of Q1 2017, down from 161 in Q4 2016.
  • Funds reported $2.39B of Agios Pharmaceuticals stock for Q1 2017, up 47% quarter-over-quarter.
  • 26 funds opened new Agios Pharmaceuticals positions in Q1 2017 and 25 closed out, a net change of +1 holder.
  • The largest Agios Pharmaceuticals buyer in Q1 2017 was BlackRock, an estimated $103M added.
  • The largest Agios Pharmaceuticals seller in Q1 2017 was Millennium Management, an estimated $9.82M sold.

Based on aggregated 13F filings for Q1 2017.